Agios Pharma (AGIO) Reports In-Line Q2 EPS

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.41), in-line with the analyst estimate of ($1.41).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Jefferies Upgrades Jackson Financial inc. (JXN) to Buy
• Jefferies Downgrades CNO Financial Group (CNO) to Hold